Synthesis, anti-HIV activity, and resistance profiles of ribose modified nucleoside phosphonates
2007; Elsevier BV; Volume: 17; Issue: 24 Linguagem: Inglês
10.1016/j.bmcl.2007.10.038
ISSN1464-3405
AutoresRichard L. Mackman, Constantine G. Boojamra, Vidya Prasad, Lijun Zhang, Kuei‐Ying Lin, Oleg V. Petrakovsky, Darius Babusis, James Chen, Janet L. Douglas, Deborah Grant, Hon C. Hui, Choung U. Kim, David Y. Markevitch, Jennifer E. Vela, Adrian S. Ray, Tomáš Cihlář,
Tópico(s)HIV Research and Treatment
ResumoA series of nucleoside phosphonate reverse transcriptase (RT) inhibitors have been synthesized and their anti-HIV activity and resistance profiles evaluated. The most potent analog [5-(6-amino-purin-9-yl)-2,5-dihydro-furan-2-yloxymethyl]-phosphonic acid (d4AP) demonstrated a HIV EC(50)=2.1 microM, and the most favorable resistance profile against HIV-1 variants with K65R, M184V or multiple thymidine analog mutations in RT.
Referência(s)